BIO.News Newsletter

Today, a closer look at what’s in the infrastructure plan for agriculture, and some thoughts on pandemic preparedness. (818 words, 4 minutes, 5 seconds)

We look at a new discovery that could help us understand how to ensure crops are resilient in the face of rising temperatures, and the hate crimes bill moving through Congress and what it means for biotech. (833 words, 4 minutes, 9 seconds) NOTE: The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) today at 1:30 PM to review six cases of rare blood clots among patients who received the Johnson & Johnson COVID-19 vaccine. Read the joint statement. 

Today, we tell you more about the science behind mRNA vaccines and Reese Witherspoon’s favorite synbio skincare. Read to the end for what to watch in D.C. this week. (737 words, 3 minutes, 41 seconds)Breaking News: The FDA and CDC call for a pause on Johnson & Johnson vaccine, The New York Times reports. We will be monitoring the FDA's press conference at 10 AM ET on YouTube.)

Congress is heading back to work—and we’ve relaunched the I AM BIO Podcast with an important episode featuring real people explaining what’s behind vaccine hesitancy. We also look at Biden administration actions last week to promote the development of SAF—including a couple things recommended by BIO. (775 words, 3 minutes, 52 seconds)

A clean fuel standard is close to becoming law in Washington State. We also look at proposed changes that would reaffirm our understanding of Bayh-Dole and support continued innovation. (775 words, 3 minutes, 52 seconds)

We’re back and feeling refreshed. We hope you got to spend some time outdoors—and if you’re vaccinated, maybe even see your family or friends. Today, we look at a new report on how we can strengthen state-level health care systems and recent environment and infrastructure news that highlights the important role of biotech. (779 words, 3 minutes, 53 seconds)

Today, we check in on the status of clean fuel legislation in several states, and look at new data on vaccine hesitancy. And on the last day of Women’s History Month, we have some advice from Merck’s Dr. Julie Gerberding. (1,076 words, 5 minutes, 22 seconds) Starting tomorrow, Good Day BIO is taking a quick spring break. Publication will resume on Thursday, April 8, though we'll be in touch if there's major breaking news. We encourage you all to get outdoors and enjoy some warmer weather this…

Have you gotten a COVID-19 vaccine? Thank biotech—and America’s IP laws. We also have details on how the world’s largest chemical producer, BIO member BASF, plans to go carbon neutral. (812 words, 4 minutes, 3 seconds) Good Day BIO is getting ready to take a quick Spring break. Starting Thursday, April 1, we'll be on hiatus for a week—so not too long. Publication will resume on Thursday, April 8. We hope you are also able to enjoy the transition to warmer weather. And stay safe!

Starting a short week with some advice from Dr. Michelle on how to tackle vaccine hesitancy among minority communities, as well as a closer look at the economic impact of America’s food and ag sector. (769 words, 3 minutes, 50 seconds) It’s Spring, and like a lot of our readers, Good Day BIO is taking a quick Spring break. Starting Thursday, April 1, we'll be on hiatus for a week—so not too long. Publication will resume on Thursday, April 8. We hope you are also able to enjoy the transition to…

Happy Friday. We recap yesterday’s hearing on health equity and explain why clinical trial diversity leads to more equitable outcomes. We also look at gene editing’s role in enhancing your summer BBQs and meet some inspiring women dedicated to animal welfare, plant genetics, and patient advocacy. (794 words, 3 minutes, 58 seconds)